Literature DB >> 33762607

Investigating heterogeneities of live mesenchymal stromal cells using AI-based label-free imaging.

Sara Imboden1, Xuanqing Liu2, Brandon S Lee3, Marie C Payne4, Cho-Jui Hsieh2, Neil Y C Lin4,3,5.   

Abstract

Mesenchymal stromal cells (MSCs) are multipotent cells that have great potential for regenerative medicine, tissue repair, and immunotherapy. Unfortunately, the outcomes of MSC-based research and therapies can be highly inconsistent and difficult to reproduce, largely due to the inherently significant heterogeneity in MSCs, which has not been well investigated. To quantify cell heterogeneity, a standard approach is to measure marker expression on the protein level via immunochemistry assays. Performing such measurements non-invasively and at scale has remained challenging as conventional methods such as flow cytometry and immunofluorescence microscopy typically require cell fixation and laborious sample preparation. Here, we developed an artificial intelligence (AI)-based method that converts transmitted light microscopy images of MSCs into quantitative measurements of protein expression levels. By training a U-Net+ conditional generative adversarial network (cGAN) model that accurately (mean [Formula: see text] = 0.77) predicts expression of 8 MSC-specific markers, we showed that expression of surface markers provides a heterogeneity characterization that is complementary to conventional cell-level morphological analyses. Using this label-free imaging method, we also observed a multi-marker temporal-spatial fluctuation of protein distributions in live MSCs. These demonstrations suggest that our AI-based microscopy can be utilized to perform quantitative, non-invasive, single-cell, and multi-marker characterizations of heterogeneous live MSC culture. Our method provides a foundational step toward the instant integrative assessment of MSC properties, which is critical for high-throughput screening and quality control in cellular therapies.

Entities:  

Year:  2021        PMID: 33762607     DOI: 10.1038/s41598-021-85905-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  52 in total

Review 1.  Heterogeneity of mesenchymal stromal cell preparations.

Authors:  A D Ho; W Wagner; W Franke
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

Review 2.  The origins of mesenchymal stromal cell heterogeneity.

Authors:  Meirav Pevsner-Fischer; Sarit Levin; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

3.  Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

Authors:  Emanuela Zappia; Simona Casazza; Enrico Pedemonte; Federica Benvenuto; Ivan Bonanni; Ezio Gerdoni; Debora Giunti; Antonella Ceravolo; Francesco Cazzanti; Francesco Frassoni; Gianluigi Mancardi; Antonio Uccelli
Journal:  Blood       Date:  2005-05-19       Impact factor: 22.113

Review 4.  Treatment of inflammatory diseases with mesenchymal stem cells.

Authors:  Robert E Newman; Dana Yoo; Michelle A LeRoux; Alla Danilkovitch-Miagkova
Journal:  Inflamm Allergy Drug Targets       Date:  2009-06

5.  Mesenchymal stem cells for treatment of CNS injury.

Authors:  Michael F Azari; Louisa Mathias; Ezgi Ozturk; David S Cram; Richard L Boyd; Steven Petratos
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

Review 6.  New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation.

Authors:  Nayoun Kim; Seok-Goo Cho
Journal:  Int J Stem Cells       Date:  2015-05       Impact factor: 2.500

Review 7.  Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials.

Authors:  Li-Tzu Wang; Chiao-Hsuan Ting; Men-Luh Yen; Ko-Jiunn Liu; Huey-Kang Sytwu; Kenneth K Wu; B Linju Yen
Journal:  J Biomed Sci       Date:  2016-11-04       Impact factor: 8.410

Review 8.  Mesenchymal Stem Cells in Sepsis and Associated Organ Dysfunction: A Promising Future or Blind Alley?

Authors:  Jan Horák; Lukáš Nalos; Vendula Martínková; Jan Beneš; Milan Štengl; Martin Matějovič
Journal:  Stem Cells Int       Date:  2017-09-14       Impact factor: 5.443

9.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

Review 10.  The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation.

Authors:  Ke Zhao; Qifa Liu
Journal:  J Hematol Oncol       Date:  2016-05-18       Impact factor: 17.388

View more
  3 in total

Review 1.  Recapitulating human myogenesis ex vivo using human pluripotent stem cells.

Authors:  Peggie Chien; Haibin Xi; April D Pyle
Journal:  Exp Cell Res       Date:  2021-12-30       Impact factor: 3.905

2.  High throughput screening of mesenchymal stem cell lines using deep learning.

Authors:  Gyuwon Kim; Jung Ho Jeon; Keonhyeok Park; Sung Won Kim; Do Hyun Kim; Seungchul Lee
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

3.  Label-free prediction of cell painting from brightfield images.

Authors:  Riku Turkki; Yinhai Wang; Jan Oscar Cross-Zamirski; Elizabeth Mouchet; Guy Williams; Carola-Bibiane Schönlieb
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.